Clinical trials
Active, not recruiting Phase 1/2 Leukemia, B-Cell trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
3 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2017 | 1 |
| 2018 | 1 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 3 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA) | 1 |
| Ossium Health, Inc. | 1 |
| St. Jude Children's Research Hospital | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Leukemia | 3 |
| Leukemia, B-Cell | 3 |
| Leukemia, Lymphoid | 2 |
| Lymphoma | 2 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 2 |
| Recurrence | 2 |
| Anemia, Refractory, with Excess of Blasts | 1 |
| Blood Protein Disorders | 1 |
| Cardiovascular Diseases | 1 |
| Dendritic Cell Sarcoma, Interdigitating | 1 |
Trials
Showing 1 to 3 of 3. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.